Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Welcome to the community hub built to collect knowledge and have discussions related to Sam Berns.
Nothing was collected or created yet.
Sam Berns
View on Wikipediafrom Wikipedia
Not found
Sam Berns
View on Grokipediafrom Grokipedia
Sampson Gordon Berns (October 23, 1996 – January 10, 2014) was an American teenager from Foxborough, Massachusetts, who lived with Hutchinson–Gilford progeria syndrome, a rare genetic disorder that causes children to age rapidly and typically leads to death from cardiovascular complications around age 13.[1][2] Diagnosed at 22 months old, Berns outlived the average lifespan for the condition, reaching 17 years through participation in groundbreaking clinical trials for the drug lonafarnib, which his parents helped pioneer.[3][1]
Born in Providence, Rhode Island, to pediatricians Leslie Gordon and Scott Berns, his diagnosis prompted his parents to co-found the Progeria Research Foundation in 1999, which has since advanced understanding of the disease's genetic cause—a mutation in the LMNA gene producing abnormal progerin protein—and supported research affecting approximately 153 identified children with the syndrome worldwide as of 2025.[4][3][5] Despite physical challenges like short stature, hair loss, and joint stiffness, Berns led an active life: he earned Eagle Scout status, played snare drum in his high school marching band, attended prom, built elaborate Lego models, and aspired to study engineering at MIT.[1][2][4]
Berns became a global advocate for progeria awareness, starring in the 2013 HBO documentary Life According to Sam, which chronicled his philosophy of focusing on happiness amid limitations, and delivering a viral TEDxMidAtlantic talk in 2013 where he shared three rules for living a happy life: having a front seat to your own life, having a best friend when you need one, and always staying positive.[3][2] His efforts helped fund research leading to the FDA's 2020 approval of lonafarnib as the first treatment for progeria, extending life expectancy to an average of about 18.7 years and reducing disease progression.[4][1][6] Berns died in Boston from progeria-related complications, leaving a legacy of inspiration that continues to drive advocacy and scientific progress in rare disease research.[3][2]
